These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10531849)

  • 1. Lispro insulin: adsorption and stability in selected intravenous devices.
    Ling J; Hu M; Hagerup T; Campbell RK
    Diabetes Educ; 1999; 25(2):237-45. PubMed ID: 10531849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro stability of insulin lispro in continuous subcutaneous insulin infusion.
    DeFelippis MR; Bell MA; Heyob JA; Storms SM
    Diabetes Technol Ther; 2006 Jun; 8(3):358-68. PubMed ID: 16800757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of insulin lispro in insulin infusion systems.
    Lougheed WD; Zinman B; Strack TR; Janis LJ; Weymouth AB; Bernstein EA; Korbas AM; Frank BH
    Diabetes Care; 1997 Jul; 20(7):1061-5. PubMed ID: 9203437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
    Roach P; Woodworth JR
    Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tubing dwell time on insulin adsorption during intravenous insulin infusions.
    Thompson CD; Vital-Carona J; Faustino EV
    Diabetes Technol Ther; 2012 Oct; 14(10):912-6. PubMed ID: 22746979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects.
    Becker RH; Frick AD; Burger F; Potgieter JH; Scholtz H
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):435-43. PubMed ID: 16151977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature.
    Teska BM; Alarcón J; Pettis RJ; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Aug; 103(8):2255-67. PubMed ID: 24909933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
    Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
    Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.
    Reichel A; Rietzsch H; Köhler HJ; Pfützner A; Gudat U; Schulze J
    Exp Clin Endocrinol Diabetes; 1998; 106(3):168-72. PubMed ID: 9710355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lispro insulin is suitable for external pumps but not for implantable pumps.
    Demirdjian S; Bardin C; Savin S; Zirinis P; Chast F; Slama G; Sélam JL
    Diabetes Care; 1998 May; 21(5):867-8. PubMed ID: 9589258
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin lispro: in-vivo potency determination by intravenous administration in conscious rabbits.
    Lin S; Wang SY; Chen EC; Chien YW
    J Pharm Pharmacol; 1999 Mar; 51(3):301-6. PubMed ID: 10344631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?
    Mazer M; Chen E
    Ann Emerg Med; 2009 Feb; 53(2):259-63. PubMed ID: 19177639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe insulin resistance treated with insulin lispro.
    Gill G; Williams G
    Lancet; 1997 Jan; 349(9046):211. PubMed ID: 9111571
    [No Abstract]   [Full Text] [Related]  

  • 16. Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.
    Bartolo PD; Pellicano F; Scaramuzza A; Sardu C; Casetti T; Bosi E; Miselli V; Brandolini S; Fabbri T; Meandri P; Cannatà F
    Diabetes Technol Ther; 2008 Dec; 10(6):495-8. PubMed ID: 19049379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
    Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L
    Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Guerci B; Meyer L; Sallé A; Charrié A; Dousset B; Ziegler O; Drouin P
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2673-8. PubMed ID: 10443658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of regular insulin or insulin LISPRO on glucose metabolism after an oral glucose load in patients with type 2 diabetes mellitus.
    Paquot N; Roulin D; Schneiter P; Ruiz J; Lefebvre P; Pahud P; Tappy L
    Diabetes Metab; 1998 Dec; 24(6):523-8. PubMed ID: 9932219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of lispro insulin for treatment of diabetic ketoacidosis in dogs.
    Sears KW; Drobatz KJ; Hess RS
    J Vet Emerg Crit Care (San Antonio); 2012 Apr; 22(2):211-8. PubMed ID: 22390184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.